Avirulent anti-rabies vaccine
CA 2100591 C · Owner: Flamand, Anne · Inventors: Coulon, Patrice; Lafay, Florence; Tuffereau, Marie-Christine
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to an avirulent anti-rabies vaccine which consists of an avirulent mutant of an SAD strain of the rabies virus the glycoprotein of which possesses in position 333 a naturally occurring amino acid whose codon differs from those of arginine by at least two nucleotides. Application: vaccination against rabies.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 20, 1993 and granted February 18, 2003. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended July 20, 2013.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 20, 2015.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.